[go: up one dir, main page]

CA973475A - Culture of a high titre strain of turkey herpes virus and method for preparation thereof suitable for the production of marek's disease vaccine - Google Patents

Culture of a high titre strain of turkey herpes virus and method for preparation thereof suitable for the production of marek's disease vaccine

Info

Publication number
CA973475A
CA973475A CA120,678A CA120678A CA973475A CA 973475 A CA973475 A CA 973475A CA 120678 A CA120678 A CA 120678A CA 973475 A CA973475 A CA 973475A
Authority
CA
Canada
Prior art keywords
marek
culture
preparation
production
herpes virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA120,678A
Other versions
CA120678S (en
Inventor
William A.M. Gregg
Kenneth F. Lawson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
Connaught Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Laboratories Ltd filed Critical Connaught Laboratories Ltd
Priority to CA120,678A priority Critical patent/CA973475A/en
Priority to JP47077335A priority patent/JPS4828622A/ja
Application granted granted Critical
Publication of CA973475A publication Critical patent/CA973475A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA120,678A 1971-08-16 1971-08-16 Culture of a high titre strain of turkey herpes virus and method for preparation thereof suitable for the production of marek's disease vaccine Expired CA973475A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA120,678A CA973475A (en) 1971-08-16 1971-08-16 Culture of a high titre strain of turkey herpes virus and method for preparation thereof suitable for the production of marek's disease vaccine
JP47077335A JPS4828622A (en) 1971-08-16 1972-08-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA120,678A CA973475A (en) 1971-08-16 1971-08-16 Culture of a high titre strain of turkey herpes virus and method for preparation thereof suitable for the production of marek's disease vaccine

Publications (1)

Publication Number Publication Date
CA973475A true CA973475A (en) 1975-08-26

Family

ID=4090612

Family Applications (1)

Application Number Title Priority Date Filing Date
CA120,678A Expired CA973475A (en) 1971-08-16 1971-08-16 Culture of a high titre strain of turkey herpes virus and method for preparation thereof suitable for the production of marek's disease vaccine

Country Status (2)

Country Link
JP (1) JPS4828622A (en)
CA (1) CA973475A (en)

Also Published As

Publication number Publication date
JPS4828622A (en) 1973-04-16

Similar Documents

Publication Publication Date Title
EP0965345A3 (en) Use of acemannan
GB1457382A (en) Process for preparing live varticella vaccines
SE7508565L (en) PREPARATION FOR THE TREATMENT OF INFECTIOUS DISEASES PROCEDURE FOR ITS PREPARATION AND USE OF A SUBSTANT PREPARATION.
DE3169848D1 (en) Herpes simplex type i fraction vaccine and process for its preparation
GB1183506A (en) New vaccines for combating influenza and the preparation thereof
GB1292803A (en) Improvements relating to the production of antigens
IE35138B1 (en) Poultry vaccine
ES8107025A1 (en) Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it.
CA1021261A (en) Herpes simplex type 2 virus vaccine and method of production and use
CA973475A (en) Culture of a high titre strain of turkey herpes virus and method for preparation thereof suitable for the production of marek's disease vaccine
IE40221L (en) Influenza vaccines
DE2966648D1 (en) Vaccine against diseases caused by reo viruses, combined vaccine with newcastle disease virus, process for preparing them and reo virus strain used for their preparation
SU579309A1 (en) Method of preparing vaccine
CA958641A (en) Equine strangles vaccine and method of preparing and using the same
YU311779A (en) Process for preparing vaccines against the virus of early summer meningoencephalitis
DE2966914D1 (en) Combined vaccine active against newcastle disease and egg production drop caused by adeno-like viruses, process for preparing it, adeno-like and newcastle disease virus strains
ZA805849B (en) Process for the preparation of novel influenza virus strains and influenza virus vaccines containing them
ES8107024A1 (en) Feline infectious peritonitis vaccine and process for its preparation.
EP0010312A3 (en) Process for the preparation of 6-hydroxymethyl-2-(beta-aminoethylthio)-1-carbadethiapen-2-em-3-carboxylic acid and intermediates useful in this process
PT69953A (en) Process for preparing a composition comprising a lyophilized herpes virus
IE40159L (en) Vaccine for marek's disease.
AU2793971A (en) Marek's disease inactivated vaccine and process for preparing the same
EP0255755A3 (en) Vaccine preparation
GB1436323A (en) Cell and virus culture systems
CA960586A (en) Infectious bovine rhinotracheitis virus vaccine and method of preparing and using the same